“announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch
“announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch
このブックマークにはスターがありません。
最初のスターをつけてみよう！
LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar for psoriasis treatment
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／